Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
Top Stories
France / Top 10 Pharma Companies
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and Servier lead the way, followed by Bayer, Janssen and Mylan. French…
France / Valneva: Small, but Poised for COVID-19 Vaccine Success
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
Switzerland / A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
Turkey / The Impact Of Brexit On CE Certificates Issued By UK Notified Bodies
The shockwaves from the UK’s exit from the European Union have resounded across the continent, including in…
APAC / Novartis APAC Oncology Head & Singapore Country President Kevin Zou
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
In Conversation
Andrew Frye – SVP & President, APAC, Baxter
Andrew Frye of medtech giant Baxter outlines his management strategy for the diverse APAC region, how growth was achieved in 2020 despite the drop in non-essential hospital visits and treatments that the COVID-19 pandemic brought about, and the increasing importance of homecare and telehealth post-pandemic. Healthcare is becoming more like a consumer market, with more discerning patients/customers now expecting…
Latest Reports
Focus on China
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
New Drug Approvals in China 2020
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals…
China: Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from…
Read more: China >>
Focus on Vaccines
Russia Pharma News: Biocad Ramps up Sputnik V Manufacturing;…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
LatAm Pharma News: COVAX Rollout in Colombia; União Quimica…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia,…
German Pharma: Highest Honours for BioNTech Founders;…
A roundup of some of the most important recent news from German pharma,…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
Read more: Vaccines >>
Focus on Europe
Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that…
Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
Can Europe’s Beating Cancer Plan Make it an Innovation…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating…
Read more: Europe >>
Focus on Singapore
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
APAC: Prestige & HH&L IPO News; Cold Chain Vaccine…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for…
Singapore Pharma Industry Snapshot 2020
Singapore is home to a wide range of biopharmaceutical company headquarters,…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
Read more: Singapore >>
Focus on MEA
MEA Roundup: Turkey’s Pharma Debt; Saudi Market Rise; UAE…
A roundup of the latest from the Middle East & Africa region, including…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…
Read more: MEA >>
Focus on USA
US FDA Drug Approvals 2020
In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved…
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and…
Read more: USA >>
Focus on Switzerland
Swiss Pharma: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland…
ISREC’s Susan Gasser: A “Hard-Nosed” Approach to…
After 15 years as director at the Friedrich Miescher Institute for Biomedical…
Swissmedic New Drug Approvals 2020
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands…
Building a Health Data Ecosystem in Switzerland
Although Switzerland is ahead of many of its competitors in Europe on levels of…